Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company

Gamida Cell , a world leader in stem cell expansion technologies and therapeutic products, announced today that it has signed an investment and option agreement with Novartis Pharma AG in Gamida Cell and in return will receive 15% equity and an option to fully acquire Gamida Cell.

http://ift.tt/1mfOs4z